Dubai, April 12 -- Habil Khorakiwala, Chairman of pharma company Wockhardt on Friday indicated that any imposition of tariffs on pharma products by the US administration would be counterproductive for the Americans.

The US now imposes a 10 per cent baseline tariff on all imported goods.

The remaining reciprocal tariffs imposed by the US on dozens of partner countries have been paused for 90 days, except for China. Faced with reciprocal tariffs, as many as 75 partner countries are actively negotiating a trade deal with the US.

Wockhardt Chairman told ANI that India supplies 40 per cent of prescription drugs to the United States.

"And over the years, we (India) made so much contribution in making products available at a reasonable price...